Efficient and easy synthesis of new Benzohchromene and Benzohquinoline derivatives as a new class of cytotoxic agents

Publication date: Available online 22 May 2019Source: Journal of Molecular StructureAuthor(s): Mogedda E. Haiba, Ebtehal S. Al-Abdullah, Nesreen S. Ahmed, Hazem A. Ghabbour, Hanem M. AwadAbstractThe present study presents easy and rapid methods to synthesize new benzo[h]chromene and benzo[h] quinoline derivatives. Cytotoxic evaluations of most of the examined compounds indicated that they had significant cytotoxic activities against HepG-2 (human cancer cells) and MCF-7 (breast cancer cells). Compounds 4 and 11 had stronger cytotoxic activity against HepG-2 human cancer cells than the reference drug Doxorubicin. All the examined compounds were significantly active against MCF-7 human cancer cells and were more potent than Doxorubicin. The structures of the new compounds were established from their spectral and elemental data. In addition the structures of benzo[h] chromene 3 and benzo[h]quinoline 7 were recognized by x-ray crystallography. Herein detailed syntheses, spectroscopic information and biological actions of the tested compounds are reported.
Source: Journal of Molecular Structure - Category: Molecular Biology Source Type: research

Related Links:

We report the application of RNA sequencing technology for high-throughput profiling of mRNA expression in breast cancer cell line
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by high throughput sequencing Homo sapiens Source Type: research
Source: Cancer Management and Research - Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
Source: Cancer Management and Research - Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
The original version of this article unfortunately contained a mistake in the article title. The captured title was “Local-Regional Evaluation and Therapy (D Euhus, Section Editor)” instead of “Ablative Treatment of Breast Cancer; Are We There Yet?”
Source: Current Breast Cancer Reports - Category: Cancer & Oncology Source Type: research
Findings seen among pre - /perimenopausal survivors of stage 0 to III breast cancer
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Endocrinology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Nursing, Oncology, Orthopedics, Rheumatology, Journal, Source Type: news
Condition:   Hormone Receptor Positive Metastatic Breast Cancer Intervention:   Other: Exercise Treatment Sponsor:   Memorial Sloan Kettering Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Metastatic Breast Cancer Interventions:   Drug: Abemaciclib;   Drug: Nonsteroidal Aromatase Inhibitor (NSAI) Sponsor:   Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Breast Cancer Interventions:   Drug: Pembrolizumab;   Drug: Trastuzumab Biosimilar ABP 980;   Drug: Pertuzumab Sponsors:   West German Study Group;   Merck Sharp & Dohme Corp.;   Amgen;   NanoString Technologies, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
MONDAY, June 17, 2019 -- Higher soy consumption is linked to fewer osteoporotic fractures in younger breast cancer survivors, according to a study published online May 21 in JNCI Cancer Spectrum. Neil Zheng, from Yale University in New Haven,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
MONDAY, June 17, 2019 -- Among black women in the United States, the prevalence of triple-negative breast cancer varies by birthplace, according to a study published online June 13 in Cancer. Hyuna Sung, Ph.D., from the American Cancer Society in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Molecular Biology | Study